1887

Chapter 2 : Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818289/9781555811303_Chap02-1.gif /docserver/preview/fulltext/10.1128/9781555818289/9781555811303_Chap02-2.gif

Abstract:

Human adenovirus, simian virus 40 (SV40), and murine polyomavirus are small DNA viruses, classified as tumor viruses because they can induce tumors in rodents and immortalize primary cells in vitro. This chapter reviews the historical role of adenovirus and SV40 in illuminating the molecular basis of retinoblastoma gene product (pRb) and p53 function. More recently recognized interactions between the transforming proteins of adenovirus, SV40, and polyomavirus and cell growth control products are considered in this chapter. Human papillomaviruses (HPVs) have small circular genomes like SV40 and polyomavirus, but they express a series of early genes more like adenovirus. The contribution of E1A and large-T-antigen studies to the current understanding of the molecular roles of p53 and the pRb family in the control of cell growth is discussed in this chapter. Interactions of the adenovirus, SV40, and polyomavirus transforming proteins are described in this chapter. The human adenoviruses, SV40, and murine polyomavirus have each contributed importantly to the understanding of the molecular events that underlie carcinogenesis. Adenovirus interactions with its human hosts are of considerable importance for at least two reasons. One is that adenovirus targets the major tumor suppressors pRb and p53 very effectively, yet, in contrast to viruses such as HPV, has never been associated with human cancer. The second reason for interest in adenovirus/human interactions is that the biological properties of adenovirus have made it an attractive gene therapy vector. These viruses provided the first clear view of the functional links between disparate families of cell cycle-regulating molecules.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2

Key Concept Ranking

Murine leukemia virus
0.48814437
Human herpesvirus 8
0.45737842
Gene Expression and Regulation
0.45284545
Simian virus 40
0.45271516
0.48814437
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Schematic representation of adenovirus genome transcription products and the translation products of the E1A and E1B transforming genes. (A) The Ad2 or Ad5 genome consists of approximately 36,000 bp of linear double-stranded DNA. Adenovirus transcribes from both strands (the direction is indicated by the arrows). The early (E) and major late transcription units are represented as bars. Each transcription unit is further processed to produce a variety of products. The early transcription units produce the transforming proteins and proteins involved in virus replication, gene expression, and host interactions. The late proteins are mostly virus structural proteins. (B) The E1A and E1B genes produce a series of mRNAs through alternate splicing. The splice junctions are represented by dashed lines. The most prominent E1A splice products early in infection are the 13S and 12S mRNAs, named for their sedimentation coefficients. The corresponding 13S and 12S proteins are translated in the same reading frame and differ only by an internal region of 46 amino acids unique to the 13S product. The 13S unique region is required for efficient transcription of the remaining viral transcription units. However, all of the functions required for transformation of rodent cells in culture are contained within the common sequence represented by the 12S product. E1B produces two distinct proteins which initiate from different reading frames and have no sequence in common. As indicated in the text, the E1B 55K product targets p53. The 19K product is a homolog of the cellular protein Bcl-2, which restricts the apoptosis response. AA, amino acids.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Linear representation of the SV40 genome and transcription products. The SV40 genome consists of 5,243 bp of circular double-stranded DNA. SV40 transcribes from sequences near the single origin of replication in the clockwise direction to produce the early mRNAs (direction of transcription represented by the rightward arrow), and in the counterclockwise direction to produce the late mRNAs (direction of transcription represented by the leftward arrow). The late transcription unit encodes the virus structural proteins (VP-1, VP-2, and VP-3). The early transcription unit is differentially spliced (the splice site is represented by the dashed line) to produce mRNAs encoding the two SV40 transforming proteins, large T and small t antigens. Large T and small t antigens share an amino-terminal region of 82 residues, followed by areas of sequence unique to each.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Linear representation of the murine polyomavirus genome and transcription products. The polyomavirus genome consists of 5,295 bp of circular double-stranded DNA with a genetic organization similar to that of SV40. Polyomavirus transcribes from sequences near the single origin of replication in the clockwise direction to produce the early mRNAs (direction of transcription represented by the rightward arrow), and in the counterclockwise direction to produce the late mRNAs (direction of transcription represented by the leftward arrow). The late transcription unit encodes the virus structural proteins (VP-1, VP-2, and VP-3). The early transcription unit is differentially spliced (the splice site junctions are represented by the dashed lines) to produce four messages encoding the early proteins: large T, middle T, small t, and tiny t antigens. All of the polyomavirus T antigens share amino-terminal protein sequence, and the carboxy-terminal sequence of small t antigen is contained within large T antigen. Small t antigen has an internal region that is not present in large T or tiny t antigens, but is common to middle T antigen. The carboxy-terminal regions of middle T antigen and tiny t antigen are unique. Despite the overall similarity of the polyomavirus and SV40 genome structures, the T antigens differ significantly between the two viruses. The large T antigens of both contain J domains and functional pRb family binding motifs. However, polyomavirus large T antigen does not show p53 binding activity and does not transform efficiently in the absence of middle T antigen. Middle T antigen is the major transforming agent of the polyomavirus genome. Its transforming activity is largely localized to its unique sequence, which encodes binding sites for a number of cytoplasmic cell proteins involved in growth factor signaling (see also Fig. 9 ).

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Schematic of the 708-residue SV40 large T antigen gene product and major protein binding sites linked with transforming activities. (A) SV40 large T antigen contains an amino-terminal J domain of approximately 80 residues which mediates interaction with cellular hsc70. This interaction promotes the degradation of pl30 and posttranslational modifications of pl07, effects that correlate with increased cell cycle activity. This interaction may have consequences for other targets of large T function as well, including components of replication complexes. The J domain is present in both the large T and small t antigens. Sequences downstream of the J domain are not common to small t antigen. These include the pRb family binding site, which is specified by the conserved Leu-X-Cys-X-Glu (LXCXE) motif. p53 is bound via two noncontiguous regions near the C terminus of the protein. The potential Bcl-2 homology domain falls between the p53 binding regions. SV40 large T antigen has a variety of other functions not indicated here. It participates directly in transcription of the SV40 late genes and interacts with the basal transcription machinery. It also participates directly in replication complexes and encodes ATPase and helicase active regions which are required for its role in replication. The murine polyomavirus large T antigen has regions of both homology and dissimilarity with SV40 large T antigen. Polyomavirus large T antigen contains an amino-terminal J domain that binds hsc70 and an LXCXE motif that mediates binding to the pRb family. However, polyomavirus large T antigen does not include a recognizable p53 binding function, nor does it transform well in the absence of middle T antigen, which has no direct homolog in SV40. The properties of middle T antigen are illustrated in Fig. 9 . (B) p53 is present in immune complexes isolated from infected cells using a monoclonal antibody reactive with large T antigen. In the autoradiogram shown, isotopically labeled cells were lysed and the lysate was immunoprecipitated with an antibody that reacts with the N-terminal region common to large T and small t antigens. Visualization of immune complexes such as this one first called attention to p53 and were the impetus for the cloning and characterization of this important cell growth regulatory molecule. Not all important associations are readily detectable in this manner. Detection of pRb association with large T antigen requires more sensitive assays, although this binding activity is readily apparent with the E1A proteins (shown in Fig. 5 ).

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 5
Figure 5

Representation of the 243-residue E1 A12S product and protein binding activities. (A) The 12S protein is represented by the bar. The break in the bar indicates the splice site, where the first and second exons are joined. Shaded regions are those that have been linked with binding activities and transforming functions. Conserved regions 1 and 2 are areas that are extensively conserved among adenoviruses of different serotypes. Conserved region 1 contributes to the nonoverlapping binding sites of both the p300 and pRb families and so is represented as a loop. The key residues required for pRb family binding are the Leu-X-Cys-X-Glu (LXCXE) motif in conserved region 2. The same motif mediates pRb binding activity in SV40 and polyomavirus large T antigens. A key residue required for p300 binding is a conserved Arg (R) at position 2 in the amino-terminal region (N). The E1A second exon contains an activity that restricts the tumorigenic potential of cells immortalized by El A. This function is linked with binding of a C-terminal binding protein (CtBP) through a conserved five-residue motif, PLDLS ( ). (B) Immune complexes isolated from infected cells using a monoclonal antibody with specificity for the carboxy-terminal region of the El A proteins show stable association with p300, CBP, and the pRb family (p105-Rb, pl07, and pl30). This autoradiogram shows an electrophoretic separation of the proteins associated with the wild-type 12S El A product. (p300 and CBP do not resolve distinguishably in the conditions of this gel.) Various E1A mutants have been generated that abrogate binding to either p300/CBP or the pRb family. Such mutants have been very useful in distinguishing the respective roles of the p300 and pRb families in pathways regulating cell growth and differentiation. Closer examination of the E1A complexes revealed that they also contain cyclin A and cyclin E, with their associated cyclin-dependent kinases, products which are not as prominent in the conditions of this gel. The presence of the cyclins in the E1A complexes is dependent on the presence of the pRb-related proteins, which led to the understanding that they do not contact E1A directly, but are associated through pl30 and pl07.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 6
Figure 6

Cellular targets of the DNA tumor virus transforming proteins. The tumor viruses have evolved similar strategies for targeting host cell pathways important for cellular proliferation and apoptosis. This diagram illustrates the roles of the major host proteins targeted by the viral protein products (gray boxes). A common target among tumor viruses is the pRb family of proteins. This protein family functions, in part, by regulating the E2F family of transcription factors. The E2F family of proteins is responsible for the transcription of many key cell cycle regulatory genes. The adenovirus E1A proteins, the SV40 and polyomavirus large T antigens (LT-ag), and the HPV E7 protein all bind directly to the pRb family of proteins. This, in turn, abrogates control of E2F transcription, allowing the cell to enter the cell cycle. Another key regulator of cell growth is p53. p53 can stop the cell cycle by upregulating, among other targets, the cyclin-dependent kinase inhibitor p21. Depending on other signals, p53 can also initiate the cell death machinery (apoptosis). Adenovirus E1B 55K, SV40 large T antigen, and the HPV E6 protein all target p53 directly. Adenovirus E1A targets p53 indirectly by binding p300, which normally serves as a transcriptional coactivator of p53. Still another way in which adenovirus targets apoptotic pathways is through its E1B19K protein product. This protein mimics the growth survival protein Bcl-2. Polyomavirus middle T antigen has evolved a different method for circumventing cell growth control. It is a plasma membrane-bound protein that targets the growth factor signal transduction cascade. Middle T antigen usurps this signal cascade by binding key components of the signaling pathway, including the Src family of tyrosine kinases (c-, c-, and c-), protein phosphatase 2A (PP2A), the Shc-Grb2 complex, 14-3-3 proteins, phosphatidylinositol 3-kinase (PI3-K), and phospholipase C (PLCγ-I).

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 7
Figure 7

Functional regions of human p53. The bar represents the 393-residue open reading frame of human p53. Major functional regions are indicated by shading. The binding sites for the Ad5 E1B 55K protein, SV40 large T antigen, and HPV E6 are indicated by lines below the bar. p300 and CBP interact with p53 in the amino-terminal activation domain, a region also involved in MDM2 (mouse double minute 2) binding. p300/CBP-mediated acetylation at a site near the carboxy terminus (represented by the asterisk) relieves the repressive effect that the carboxy-terminal regulatory domain exerts on p53 site-specific DNA binding. This permits p53 to bind to DNA target sequences with greater affinity and increases transcription of p53 targets such as the cyclin-dependent kinase inhibitor, p21, which inhibits cell cycle progression (see also Fig. 6 ).

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 8
Figure 8

Functions of p300. (A) The bar represents the 2,414-residue open reading frame of p300. At least four distinguishable protein binding sites have been identified in p300 and are indicated by shading. An amino-terminal region binds various nuclear hormone receptors including the retinoic acid receptor, the estrogen receptor, and the glucocorticoid receptor. p300 contains a binding site for the cyclic AMP-responsive element binding protein (CREB). The CREB binding region also serves as a binding site for various other transcription factors including c- and c-. p300 contains a bromodomain, but no specific function has yet been linked with this motif. p300 has both intrinsic and associated histone acetyltransferase (HAT) activities. Associated acetylases include P/CAF (p300/CBP-associated factor). p300 also contains an intrinsic HAT activity, which maps to the region indicated by the line below the bar. p300 has at least one other protein binding region, a region near the carboxy terminus which binds the nuclear hormone receptor cofactor SRC-1. Sequences in this region also mediate binding to other transcription factors including YY-1. The binding site for p53 association has not yet been localized definitively on p300. In addition to binding various upstream activators of transcription, p300 interacts with the basal transcription machinery. p300 and CBP are stably associated with TBP (TATA binding protein) complexes in vivo, and p300 binds directly in vitro to TFIIB (transcription factor IIB) at a region similar to that used by P/CAF. (B). The combination of properties, binding to upstream activators, association with the basal transcription machinery, and the presence of HAT activity suggests that p300 integrates signals from each of these sources. p300 can bind multiple upstream activators and/or cofactors simultaneously and thus has the potential to synergize the effects of these molecules. Similarly, p300 can connect upstream activation signals to the basal transcription machinery. The HAT activity may contribute to transcriptional activation through multiple channels. p300 can acetylate histones, suggesting that it contributes to chromatin remodeling. p300 can also mediate acetylation of at least one upstream activator, p53. This acetylation enhances p53 site-specific DNA binding activity and consequent transactivation function. Acetylation of components of the basal transcription machinery may also be an aspect of p300 function.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 9
Figure 9

Binding activities of murine polyomavirus middle T antigen. The bar represents the 421-residue open reading frame of murine polyomavirus middle T antigen. Major functional regions are indicated by shading. The amino-terminal 79 residues comprise a J domain motif, which mediates interaction with the cellular hsc70 protein. The approximate binding sites for PP2A and various cell signaling molecules bound by middle T antigen are also indicated. Middle T antigen binds c- (and other family members including c- and c-). c- binding is mediated by two Cys-X-Cys-X-X-Cys motifs (2X-CXCXXC). Binding activates the tyrosine kinase activity of the src family members and promotes tyrosine phosphorylation at sites indicated by “Y.” Phosphorylation at these sites in turn promotes the binding of other signal transfer proteins, including the Shc-Grb2 complex, phosphatidylinositol 3-kinase (PI3-K), and PLC-γ-1. Middle T antigen also binds 14-3-3 proteins. Binding of these proteins promotes cell growth signals in a manner analogous to the binding of growth factors to plasma membrane receptors (see also Fig. 6 ). The polyomavirus small t antigen shares the J domain sequence with the other T antigens. Additional sequence shared with middle T antigen includes the PP2A binding region, but does not include functions downstream of PP2A binding (see also Fig. 3 ). The more recently discovered tiny t antigen also shares the J domain sequence and associated hsc70 binding function.

Citation: Beck, Jr. G, Zerler B, Moran E. 1998. Introduction to DNA Tumor Viruses: Adenovirus, Simian Virus 40, and Polyomavirus, p 51-86. In McCance D (ed), Human Tumor Viruses. ASM Press, Washington, DC. doi: 10.1128/9781555818289.ch2
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818289.chap2
1. Arany, Z.,, W. R. Sellers,, D. M. Livingston,, and R. Eckner. 1994. ElA-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799800.
2. Auger, K. R.,, C. L. Carpenter,, S. E. Shoelson,, H. Piwnica-Worms,, and L. C. Cantley. 1992. Polyomavirus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J. Biol. Chem. 267:54085415.
3. Avantagiatti, M. L.,, V. Ogryzko,, K. Gardner,, A. Giordano,, A. S. Levine,, and K. Kelly. 1997. Recruitment of p300/CBP in p53 dependent pathways. Cell 89:11751184.
4. Bagchi, S.,, P. Raychaudhuri,, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A-transactivation. Cell 62:659669.
5. Bandara, L. R.,, J. P. Adamczewski,, T. Hunt,, and N. B. La Thangue. 1991. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352:249251.
6. Bandara, L. R.,, and N. B. La Thangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351: 494507.
7. Barbeau, D.,, R. Charbonneau,, S. G. Whalen,, S. T. Bayley,, and P. E. Branton. 1994. Functional interactions within adenovirus E1A protein complexes. Oncogene 9: 359373.
8. Bayley, S. T.,, and J. S. Mymryk. 1994. Adenovirus E1A proteins and transformation (review), Internat. J. Oncol. 5:425444.
9. Beijersbergen, R. L.,, and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103120.
10. Berk, A. J.,, and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of SI endonuclease-digested hybrids. Cell 12:721732.
11. Bikel, I.,, X. Montano,, M. E. Agha,, M. Brown,, M. McCormack,, J. Boltax,, and D. M. Livingston. 1987. SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell 48:321330.
12. Bolen, J. B.,, C. J. Thiele,, M. A. Israel,, W. Yonemoto,, L. A. Lipsich,, and J. S. Brugge. 1984. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyomavirus infection and transformation. Cell 38:767777.
13. Bondesson, M.,, K. Ohman,, M. Manervik,, S. Fan,, and G. Akusjarvi. 1996. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting El A transactivation of the E4 promoter. J. Virol. 70:38443851.
14. Bouck, N.,, N. Beales,, T. Shenk,, P. Berg,, and G. di Mayorca. 1978. New region of the simian virus 40 genome required for efficient viral transformation. Proc. Natl. Acad. Sci. USA 75:24732477.
15. Boulakia, C. A.,, G. Chen,, F. W. Ng,, J. G. Teodoro,, P. E. Branton,, D. W. Nicholson,, G. G. Poirier,, and G. C. Shore. 1996. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 12(3):529535.
16. Boyd, J. M.,, S. Malstrom,, T. Subramanian,, L. K. Venkatesh,, U. Schaeper,, B. Elangovan,, C. D'Sa-Eipper,, and G. Chinnadurai. 1994. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341351.
17. Buchkovich, K.,, L. A. Duffy,, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:10971105.
18. Burkhardt, A. L.,, J. B. Bolen,, E. Kieff,, and R. Longnecker. 1992. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66:51615167.
19. Campbell, K. S.,, K. P. Mullane,, I. A. Aksoy,, H. Stubdal,, J. Zalvide,, J. M. Pipas,, P. A. Silver,, T. M. Roberts,, B. S. Schaffhausen,, and J. A. DeCaprio. 1997. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev. 11:10981110.
20. Campbell, K. S.,, E. Ogris,, B. Burke,, W. Su,, K. R. Auger,, B. J. Druker,, B. S. Schaffhausen,, T. M. Roberts,, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:63446348.
21. Chakravarti, D.,, V. La Morte,, M. Nelson,, T. Nakajima,, I. G. Schulman,, H. Juguilon,, M. Montminy,, and R. Evans. 1996. Role of CBP/p300 in nuclear receptor signalling. Nature 383:99103.
22. Chellappan, S. P.,, S. Hiebert,, M. Mudryj,, J. R. Horowitz,, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:10531061.
23. Chellappan, S.,, V. B. Kraus,, B. Kroger,, K. Munger,, P. M. Howley,, W. C. Phelps,, and J. R. Nevins. 1991. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci USA 89:45494553.
24. Chen, P. L.,, P. Scully,, J. Y. Shew,, J. Y. Wang,, and W. H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:11931198.
25. Cheng, E. H.,, J. Nicholas,, D. S. Bellows,, G. S. Hayward,, H. G. Guo,, M. S. Reitz,, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690694.
26. Cheng, S. H.,, R. Harvey,, P. C. Espino,, K. Samba,, T. Yamamoto,, K. Toyoshima,, and A. E. Smith. 1988. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J. 7:38453855.
27. Chittenden, T.,, D. M. Livingston,, and W. G. Kaelin, Jr. 1991. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific binding protein. Cell 65:10731082.
28. Chrivia, J. C.,, R. P. S. Kwok,, N. Lamb,, M. Hagiwara,, M. R. Montminy,, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855859.
29. Clemens, M. J.,, K. G. Laing,, I. W. Jeffrey,, A. Schofield,, T. V. Sharp,, A. Edia,, V. Marys,, M. C. James,, and V. J. Tilleray. 1994. Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs. Biochimir 76:770778.
30. Cole, C., 1996. Polyomavirinae: the viruses and their replication, p. 917946. In B. N. Fields,, D. M. Knipe,, and P. M. Howley (ed.), Fundamental Virology, 3rd ed. Lippincott-Raven, Philadelphia.
31. Conzen, S. D.,, C. A. Snay,, and C. N. Cole. 1997. Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen. J. Virol. 71:45364543.
32. Courtneidge, S. A.,, and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435439.
33. Courtneidge, S. A.,, and A. E. Smith. 1984. The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J. 3:585591.
34. Cox, J. H.,, J. R. Bennink,, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174:16291637.
35. Cress, W. D.,, and J. R. Nevins. 1996. Use of the E2F transcription factor by DNA tumor virus regulatory proteins. Curr. Top. Microbiol. Immunol. 208:6378.
36. Crook, T.,, J. A. Tidy,, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547556.
37. Dallas, P. B.,, P. Yaciuk,, and E. Moran. 1997. Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J. Virol. 71:17261731.
38. DeCaprio, J. A.,, J. W. Ludlow,, J. Figge,, J. Y. Shew,, C. M. Huang,, W.-H. Lee,, E. Marsilio,, E. Paucha,, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma-susceptibility gene. Cell 54:275283.
39. DeCaprio, J. A.,, J. W. Ludlow,, D. Lynch,, Y. Furukawa,, J. Griffin,, H. Piwnica-Worms,, C. M. Huang,, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:10851095.
40. Dilworth, S. M.,, C. E. Brewster,, M. D. Jones,, L. Lanfrancone,, G. Pelicci,, and P. G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of She. Nature 367:8790.
41. Dimitrov, T.,, P. Krajcsi,, T. W. Hermiston,, A. E. Tollefson,, M. Hannink,, and W. S. Wold. 1997. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J. Virol. 71:28302837.
42. Doerfler, W. 1968. The fate of the DNA of adenovirus type 12 in baby hamster kidney cells. Proc. Natl. Acad. Sci. USA 60:636643.
43. Douglas, J. L.,, S. Gopalakrishnan,, and M. P. Quinlan. 1991. Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A12S gene. Oncogene 6:20932103.
44. Dunaief, J. L.,, B. E. Strober,, S. Guha,, P. A. Khavari,, K. Alin,, J. Luban,, M. Begemann,, G. R. Crabtree,, and S. P. Goff. 1994. The retinoblastoma protein and BRG-1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119130.
45. Dyson, N.,, and E. Harlow. 1992. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12:161195.
46. Dyson, N.,, P. M. Howley,, K. Munger,, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934937.
47. Eckner, R. 1996. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377:685688.
48. Eckner, R.,, M. E. Ewen,, D. Newsome,, J. A. DeCaprio,, J. B. Lawrence,, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kd protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869884.
49. Eddy, B. E.,, G. S. Borman,, G. E. Grubbs,, and R. D. Young. 1962. Identification of the oncogenic substance in rhesus monkey cell kidney cell cultures as simian virus 40. Virology 17:6575.
50. Egan, C.,, T. N. Jelsma,, J. A. Howe,, S. T. Bayley,, B. Ferguson,, and P. E. Branton. 1988. Mapping of cellular protein-binding sites on the products of early region 1A of human adenovirus type 5. Mol. Cell. Biol. 8:39553959.
51. Elia, A.,, K. G. Laing,, A. Schof ield,, V. J. Tilleray,, and M. J. Clemens. 1996. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 24:44714478.
52. Eliyahu, D.,, N. Goldfinger,, O. Pinhasi-Kimhi,, G. Shaulsky,, Y. Shurnik,, N. Aral,, V. Rotter,, and M. Oren. 1988. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 3:313321.
53. Eliyahu, D.,, A. Raz,, P. Grass,, D. Givol,, and M. Oren. 1984. Participation of p53 cellular tumor antigen in transformation of normal embryonic cells. Nature 312: 646649.
54. Ewen, M. E.,, B. Faha,, E. Harlow,, and D. M. Livingston. 1992. Interaction of pl07 with cyclin A independent of complex formation with viral oncoproteins. Science 255:8587.
55. Ewen, M. E.,, Y. G. Xing,, J. B. Lawrence,, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for pl07, a retinoblastoma gene product-related protein. Cell 66:11551164.
56. Faha, B.,, M. E. Ewen,, L.-H. Tsal,, D. M. Livingston,, and E. Harlow. 1992. Interaction between human cyclin A and adenovirus E1A-associated pl07 protein. Science 255: 8790.
57. Faha, B.,, E. Harlow,, and E. Lees. 1993. The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2. J. Virol. 67:24562465.
58. Farrow, S. N.,, J. H. White,, I. Martinou,, T. Raven,, K. T. Pun,, C. J. Grinham,, J. C. Martinou,, and R. Brown. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731733.
59. Finlay, C. A.,, P. W. Hinds,, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:10831093.
60. Frisch, S. M. 1994. E1A induces the expression of epithelial characteristics. J. Cell. Biol. 127:10851096.
61. Gallimore, P. H.,, P. A. Sharp,, and J. Sambrook. 1974. Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA in nine lines of transformed rat cells using specific fragments of the viral genome. J. Mol. Biol. 89:4972.
62. Gardner, S. D.,, A. M. Field,, D. V. Coleman,, and B. Hulme. 1971. New human papovavirus (B. K.) isolated from urine after renal transplantation. Lancet 1: 12531257.
63. Giordano, A.,, C. McCall,, P. Whyte,, and B. R. Franza. 1991. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene 6:481486.
64. Girardi, A. J.,, B. H. Sweet,, V. B. Slotnick,, and M. R. Hilleman. 1962. Development of tumors in hamsters inoculated in the neo-natal period with vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 109:649660.
65. Gooding, L. R.,, L. Aquino,, P. J. Duerksen-Hughes,, D. Day,, T. M. Horton,, S. Yei,, and W. S. M. Wold. 1991. The E1B-19K protein of group C adenoviruses prevents cytolysis by tumor necrosis factor of human cells but not mouse cells. J. Virol. 65: 30833094.
66. Gooding, L. R.,, L. W. Elmore,, A. E. Tollefson,, H. A. Brady,, and W. S. M. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341346.
67. Gooding, L. R.,, R. Ranheim,, A. E. Tollefson,, L. Aquino,, P. Duerksen-Hughes,, T. M. Horton,, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:41144123.
68. Gottlieb, T. M.,, and M. Oren. 1996. p53 in growth and control of neoplasia. Biochim. Biophys. Acta 1287:77102.
69. Graham, F. L.,, P. J. Abrahams,, C. Mulder,, H. L. Heijneker,, S. O. Warnaar,, F. A. De Vries,, W. Fiers,, and A. J. van der Eb. 1975. Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harbor Symp. Quant. Biol. 39:637650.
70. Graham, F. L.,, A. J. van der Eb,, and H. L. Heijneker. 1974. Size and location of the transforming region in human adenovirus type 5 DNA. Nature 251:687691.
71. Gross, L. 1953. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 83:414421.
72. Gu, W.,, and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595606.
73. Gu, W.,, X.-L. Shi,, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819822.
74. Han, J.,, P. Sabbatini,, and E. White. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:58575864.
75. Hannon, G. J.,, D. Demetrick,, and D. Beach. 1993. Isolation of the Rb-related pl30 through its interaction with CDK2 and cyclins. Genes Dev. 7:23782391.
76. Hanstein, B.,, R. Eckner,, J. DiRenzo,, S. Halachmi,, H. Liu,, B. Searcy,, R. Kurokawa,, and M. Brown. 1996. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93:1154011545.
77. Harlow, E.,, P. Whyte,, B. R. Franza, Jr., and C. Schley. 1986. Association of adenovirus early region 1 proteins with cellular polypeptides. Mol. Cell. Biol. 6:15791589.
78. Hashimoto, S.,, A. Ishii,, and S. Yonehara. 1991. The E1B oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3:343351.
79. Hawkins, C. J.,, and D. L. Vaux. 1997. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system. (Review.) Semin. Immunol. 9:2533.
80. Heck, D. V.,, C. L. Yee,, P. M. Howley,, and K. Munger. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA. 89:44424446.
81. Heise, C.,, A. Sampson-Johannes,, A. Williams,, F. McCormick,, D. D. Von Hoff,, and D. H. Kirn. 1997. ONYX-015, an ElB-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:639645.
82. Helin, K.,, J. A. Lees,, M. Vidal,, N. Dyson,, E. Harlow,, and A. Fatteay. 1992. A cDNA encoding a pRB binding protein with the properties of the transcription factor E2F. Cell 70:337350.
83. Henderson, S.,, D. Huen,, M. Rowe,, C. Dawson,, G. Johnson,, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:84798483.
84. Hollstein, M.,, D. Sidransky,, B. Vogelstein,, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:4953.
85. Horak, I. D.,, T. Kawakami,, F. Gregory,, K. C. Robbins,, and J. B. Bolen. 1989. Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells. J. Virol. 63:23432347.
86. Houweling, A.,, P. J. van den Elsen,, and A. J. van der Eb. 1980. Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology 105:537550.
87. Howe, J. A.,, and S. T. Bayley. 1992. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology 186:1524.
88. Howley, P. M.,, A. J. Levine,, F. P. Li,, D. M. Livingston,, and A. S. Rabson. 1991. Lack of SV40 DNA in tumors from scientists working with SV40 virus. N. Engl. J. Med. 324:494.
89. Huibregtse, J. M.,, M. Scheffner,, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus type 16 or 18. EMBO J. 10:41294135.
90. Huibregtse, J. M.,, M. Scheffner,, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775784.
91. Huibregtse, J. M.,, M. Scheffner,, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell Biol. 13:49184927.
92. Ibaraki, T.,, M. Satake,, N. Kurai,, M. Ichijo,, and Y. Ito. 1993. Transactivating activities of the E7 genes of several types of human papillomavirus. Virus Genes 7(2):187192.
93. Jansen-Durr, P. 1996. How viral oncogenes make the cell cycle. Trends Genet. 12: 270275.
94. Jenkins, J. R.,, K. Rudge,, and G. A. Currie. 1984. Cellular immortalization by a cDNA clone encoding the transformation associated phosphoprotein p53. Nature 312: 651654.
95. Kaelin, W. G., Jr.,, W. Krek,, W. R. Sellers,, J. A. DeCaprio,, F. Ajchenbaum,, C. S. Fuchs,, T. Chittenden,, Y. Li,, P. J. Farnham,, and M. A. Blanar. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351364.
96. Kamei,, Y. L. Xu,, T. Heinzel,, J. Torchia,, R. Kurokawa,, B. Gloss,, S.-C. Lin,, R. A. Heyman,, D. W. Rose,, C. K. Glass,, and M. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403414.
97. Kelley, W. L.,, and C. Georgopoulos. 1997. The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc. Natl. Acad. Sci. USA 94:36793684.
98. Kleinberger, T.,, and T. Shenk. 1993. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates ElA-enhanced junB transcription. J. Virol. 67:75567560.
99. Knudson, A. G. 1996. Hereditary cancer: two hits revisited. J. Cancer Res. Clin. Oncol. 122:135140.
100. Ko, L. J.,, and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:10541072.
101. Kornbluth, S.,, M. Sudol,, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature 325:171173.
102. Kring, S. C.,, and K. R. Spindler. 1996. Lack of effect of mouse adenovirus type I infection on cell surface expression of major histocompatibility complex class I antigens. J. Virol. 70:54955502.
103. Kwok, R. P. S.,, J. R. Lundblad,, J. C. Chrivia,, J. P. Richards,, H. P. Bachinger,, R. G. Brennan,, S. G. E. Roberts,, M. R. Green,, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223226.
104. Kypta, R. M.,, A. Hemming,, and S. A. Courtneidge. 1988. Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyomavirus transformed cells. EMBO J. 7:38373844.
105. La Thangue, N. B. 1994. DRTF1/E2F1: an expanding family of heteromeric transcription factors implicated in cell cycle control. Trends Biol. Sci. 19:108114.
106. La Thangue, N. B. 1996. E2F and the molecular mechanisms of early cell-cycle control. Bioch. Soc. Trans. 24(l):5459.
107. Lane, D. P.,, and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261263.
108. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323331.
109. Li, Y.,, C. Graham,, S. Lacy,, A. M. V. Duncan,, and P. Whyte. 1993. The adenovirus ElA-associated 130-Kd protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:23662377.
110. Lill, N. L.,, S. R. Grossman,, D. Ginsburg,, J. DeCaprio,, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823827.
111. Lill, N. L.,, M. J. Tevethia,, R. Eckner,, D. M. Livingston,, and N. Modjtahedi. 1997. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71:129137.
112. Lillie, J. W.,, M. Green,, and M. R. Green. 1986. An adenovirus El A protein region required for transformation and transcriptional repression. Cell 46:10431051.
113. Linder, S.,, P. Popowicz,, C. Svensson,, H. Marshall,, M. Bondesson,, and G. Akusjarvi. 1992. Enhance invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxy-terminal exon. Oncogene 7:439443.
114. Linzer, D. I.,, and A. J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:4352.
115. Loeken, M. R. 1992. Simian virus 40 small t antigen transactivates the adenovirus E2A promoter by using mechanisms distinct from those used by adenovirus E1A. J. Virol. 66:25512555.
116. Longnecker, R.,, B. Druker,, T. M. Roberts,, and E. Kieff. 1991. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:36813692.
117. Ludlow, J. W. 1993. Interactions between SV40 large-tumor antigen and the growth suppressor proteins, pRB and p53. FASEB J. 7:866871.
118. Ludlow, J. W.,, J. A. DeCaprio,, C.-M. Huang,, W.-H. Lee,, E. Paucha,, and D. M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:5765.
119. Ludlow, J. W.,, J. Shon,, J. M. Pipas,, D. M. Livingston,, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387396.
120. Mackey, J. K.,, P. M. Rigden,, and M. Green. 1976. Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming sequences. Proc. Natl. Acad. Sci. USA 73:46574661.
121. Mansur, C. P.,, B. Marcus,, S. Dalai,, and E. J. Androphy. 1995. The domain of p53 required for binding HPV E6 is separable from the degradation domain. Oncogene 10:457465.
122. Mathews, M. B. 1995. Structure, function, and evolution of adenovirus virus-associated RNAs. Curr. Top. Microbiol. Immunol. 199:173187.
123. Mayol, X.,, and X. Grana,. 1997. pRB, pl07 and pl30 as transcriptional regulators: role in cell growth and differentiation, p. 157169. In L. Meijier,, S. Guidet,, and M. Phillipe (ed.), Progress in Cell Cycle Research, vol. 3. Plenum Press, New York.
124. Mayol, X.,, X. Grana,, A. Baldi,, N. Sang,, Q. Hu,, and A. Giordano. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:25612566.
125. Messerschmitt, A. S.,, N. Dunant,, and K. Ballmer-Hofer. 1997. DNA tumor viruses and Src family tyrosine kinases, an intimate relationship. (Minireview.) Virology 227: 271280.
126. Mietz, J. A.,, T. Unger,, J. M. Huibregtse,, and P. M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:50135020.
127. Mihara, K.,, X. R. Cao,, A. Yen,, S. Chandler,, B. Driscoll,, A. L. Murphree,, A. T'Ang,, and Y. K. Fung. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:13001303.
128. Momand, J.,, G. P. Zambetti,, D. C. Olson,, D. George,, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:12371245.
129. Moran, E. 1988. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A gene products. Nature 334:168170.
130. Moran, E. 1994. Cell growth control mechanisms reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol. 5:327340.
131. Moran, E.,, B. Zerler,, T. M. Harrison,, and M. B. Mathews. 1986. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol. Cell. Biol. 6:34703480.
132. Mortimer, E. A., Jr.,, M. L. Lepow,, E. Gold,, F. C. Robbins,, G. J. Burton,, and J. F. Fraumeni, Jr. 1981. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N. Engl. J. Med. 305:15171518.
133. Mudryj, M.,, S. H. Devoto,, S. W. Hiebert,, T. Hunter,, J. Pines,, and J. R. Nevins. 1991. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65:12431253.
134. Munaf, A.,, N. R. Lemoine,, and C. J. A. Ring. 1994. The use of DNA viruses and vectors for gene therapy. Gene Ther. 1:367384.
135. Ogryzko, V. V.,, R. L. Schlitz,, V. Russanova,, B. H. Howard,, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953959.
136. Oliner, J. D.,, K. W. Kinzler,, P. S. Meltzer,, D. L. George,, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:8083.
137. Oltvai, Z. N.,, C. L. Milliman,, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609619.
138. Padgett, B. L.,, D. L. Walker,, G. M. ZuRhein,, R. J. Eckroade,, and B. H. Dessel. 1971. Cultivation of a papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1:12571260.
139. Paggi, M. G.,, A. Baldi,, F. Bonetto,, and A. Giordano. 1996. Retinoblastoma protein family in cell cycle and cancer: a review. J. Cell. Biochem. 62:418430.
140. Pallas, D. C.,, H. Fu,, L. C. Haehnel,, W. Weller,, R. J. Collier,, and T. M. Roberts. 1994. Association of polomavirus middle tumor antigen with 14-3-3 proteins. Science 265:535537.
141. Pallas, D. C.,, L. K. Shahrik,, B. L. Martin,, S. Jaspers,, T. B. Miller,, D. L. Brautigan,, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167176.
142. Parada, L. F.,, H. Land,, R. A. Weinberg,, D. Wolf,, and W. Rotter. 1984. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation. Nature 312:649651.
143. Pearson, G. R.,, J. Luka,, L. Petti,, J. Sample,, M. Birkenbach,, D. Braun,, and E. Kieff. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151161.
144. Peterson, C. L.,, and J. W. Tamkun. 1995. The SWI-SNF complex: a chromatin remodelling machine. Trends Biochem. Sci. 20:143146.
145. Pines, J.,, and T. Hunter. 1990. Human cyclin A is adenovirus ElA-associated protein p60 and behaves differently from cyclin B. Nature 346:760763.
146. Porter, A. G.,, P. Ng,, and R. U. Janicke. 1997. Death substrates come alive. Bioessays 19:501507.
147. Pozzatti, R.,, M. McCormick,, M. A. Thompson,, and G. Khoury. 1988. The Ela gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol. Cell. Biol. 8:29842988.
148. Rao, L.,, M. Debbas,, P. Sabbatini,, D. Hockenbery,, S. Korsmeyer,, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bci-2 proteins. Proc. Natl. Acad. Sci. USA 89:77427746.
149. Raychaudhuri, P.,, S. Bagchi,, S. H. Devoto,, V. B. Kraus,, E. Moran,, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:12001211.
150. Riley, M. I.,, W. Yoo,, N. Y. Mda,, and W. R. Folk. 1997. Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain. J. Virol. 71:60686074.
151. Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602606.
152. Sarnow, P.,, Y. S. Ho,, J. Williams,, and A. J. Levine. 1982. Adenovirus ElB-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein. Cell 28:387394.
153. Sawal, E. T.,, and J. S. Butel. 1989. Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J. Virol. 63:39613973.
154. Schaeper, U.,, J. M. Boyd,, S. Verma,, E. Uhlmann,, T. Subramanian,, and G. Chinnadural. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA 92: 1046710471.
155. Scheffner, M.,, B. A. Werness,, J. M. Huibregtse,, A. J. Levine,, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus 16 and 18 promotes the degradation of p53. Cell 63:11291136.
156. Scolnick, D. M.,, N. Chehab,, E. S. Stavridi,, M. Lien,, L. Caruso,, E. Moran,, S. L. Berger,, and T. D. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:36933696.
157. Segawa, K.,, and Y. Ito. 1982. Differential subcellular localization of in vivo phosphorylated and non-phosphorylated middle-sized tumor antigen of polyomavirus and its relationship to middle-sized tumor antigen phosphorylating activity in vitro. Proc. Natl. Acad. Sci. USA 79:68126816.
158. Shan, B.,, X. Zhu,, P.-L. Chen,, T. Durfee,, Y. Yang,, D. Sharp,, and W.-H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:56205631.
159. Sharp, P. A.,, U. Pettersson,, and J. Sambrook. 1974. Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome. J. Mol. Biol. 86:709726.
160. Shenk, T., 1996. Adenoviridae: the viruses and their replication, p. 9791016. In B. N. Fields,, D. M. Knipe,, and P. M. Howley (ed.), Fundamental Virology, 3rd ed. Lippincott-Raven, Philadelphia.
161. Shope, R. E.,, and E. W. Hurst. 1993. Infectious papillomatosis of rabbits; with a note on the histopathology. J. Exp. Med. 58:607624.
162. Sidle, A.,, C. Palaty,, P. Dirks,, O. Wiggan,, M. Kiess,, R. M. Gill,, A. K. Wong,, and P. Hamel. 1996. Activity of the retinoblastoma family of proteins, PRB, pl07, and pl30, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol. 31:237271.
163. Slansky, J. E.,, and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208:130.
164. Srinivasan, A.,, A. J. McClellan,, J. Vartikar,, I. Marks,, P. Cantalupo,, Y. Li,, P. Whyte,, K. Rundell,, J. L. Brodsky,, and J. M. Pipas. 1997. The amino-terminal transforming region of simian virus large T and small t antigens functions as a J domain. Mol. Cell. Biol. 17:47614773.
165. Stewart, S. E.,, B. E. Eddy,, and N. G. Borgese. 1958. Neoplasms in mice inoculated with a tumor agent carried in tissue culture. J. Natl. Cancer Inst. 20:12231243.
166. Stratford-Perricaudet, L. D.,, J. F. Levrero,, M. Chasse,, M. Perricaudet,, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Human Gene Ther. 1:241256.
167. Stubdal, H.,, J. Zalvide,, K. S. Campbell,, C. Schweitzer,, T. M. Roberts,, and J. A. DeCaprio. 1997. Inactivation of pRB-related proteins pl30 and pl07 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17:49794990.
168. Su, W.,, W. Liu,, B. S. Schaffhausen,, and T. M. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270: 1233112334.
169. Subramanian, T.,, M. La Regina,, and G. Chinnadurai. 1989. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of Ela protein. Oncogene 4:415420.
170. Subramanian, T.,, B. Tarodi,, and G. Chinnadurai. 1995. Functional similarity between adenovirus E1B 19-kDa protein and proteins encoded by Bcl-2 proto-oncogene and Epstein-Barr virus BHRF1 gene. Curr. Top. Microbiol. Immunol. 199(Part 1): 153161.
171. Tarodi, B.,, T. Subramanian,, and G. Chinnadurai. 1993. Functional similarity between adenovirus E1B 19K gene and bcl2 oncogene: mutant complementation and suppression of cell death induced by DNA damaging agents. Int.J. Oncol. 3:467472.
172. Templeton, D.,, and W. Eckhart. 1982. Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation. J. Virol. 41:10141024.
173. Tollefson, A. E.,, A. Scaria,, T. W. Hermiston,, J. S. Ryers,, L. J. Wold,, and W. S. Wold. 1996. The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of virus from infected cells. J. Virol. 70: 22962306.
174. Treisman, R.,, A. Cowie,, J. Favaloro,, P. Jat,, and R. Kamen. 1981. The structures of the spliced mRNAs encoding polyoma virus early region proteins. J. Mol. Appl. Genet. 1:8392.
175. Treisman, R.,, U. Novak,, J. Favaloro,, and R. Kamen. 1981. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 292:595600.
176. Trentin, J. J.,, Y. Yabe,, and G. Taylor. 1962. The quest for human cancer viruses. Science 137:835849.
177. Tsujimoto, Y.,, and C. M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83:52145418.
178. Vogelstein, B.,, and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70: 523526.
179. Walter, G.,, R. Ruediger,, C. Slaughter,, and M. Mumby. 1990. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:25212525.
180. Wang, H.-G. H.,, E. Moran,, and P. Yaciuk. 1995. E1A promotes association between p300 and pRB in multimeric complexes that are required for normal biological activity. J. Virol. 69:79177924.
181. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323330.
182. Werness, B. A.,, A. J. Levine,, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:7679.
183. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:115.
184. White, E.,, P. Sabbatini,, M. Debbas,, W. S. Wold,, D. I. Kusher,, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12: 25702580.
185. Whyte, P.,, K. Buchkovich,, J. M. Horowitz,, S. H. Friend,, M. Raybuck,, R. A. Weinberg,, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124129.
186. Whyte, P.,, N. M. Williamson,, and E. Harlow. 1989. Cellular targets for transformation by the E1A proteins. Cell 56:6775.
187. Wold, W. S.,, A. E. Tollefson,, and T. W. Hermiston. 1995. E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol. 199(Part l):237274.
188. Wu, D. Y.,, G. V. Kalpana,, S. P. Goff,, and W. H. Schubach. 1996. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. J. Virol. 70:60206028.
189. Yang, X.-J.,, V. V. Ogryzkp,, J.-I. Nishikawa,, B. H. Howard,, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319324.
190. Yee, S.,, and P. Branton. 1985. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology 147:142153.
191. Yew, P. R.,, and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early IB protein. Nature 357:8285.
192. Zerler, B.,, E. Moran,, K. Maruyama,, J. Moomaw,, T. Grodzicker,, and H. E. Ruley. 1986. Analysis of adenovirus E1A coding sequences which enable ras and pmt oncogenes to transform cultured primary cells. Mol. Cell. Biol. 6:887899.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error